Finally, it should be highlighted that USP22 also targets additional substrates beyond H2Bub1, including SIRT1, FBP1 and Cyclin D1 (reviewed in [76]), and thus it will be important to establish whether they also impact CIN. The gene discussed is FBP1; the disease is cervical squamous intraepithelial neoplasia.